Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 133


Tick bites in the Lyme light.

Barton-Forbes M, Leonard E, Lindsay LR, Langley JM, Koffi JK, Ogden NH.

Paediatr Child Health. 2015 Jun-Jul;20(5):237-8. No abstract available.


Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

MacDougall D, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

Hum Vaccin Immunother. 2015 Sep 2;11(9):2167-79. doi: 10.1080/21645515.2015.1046662. Epub 2015 Jun 19.


Against vaccine assay secrecy.

Herder M, Hatchette TF, Halperin SA, Langley JM.

Hum Vaccin Immunother. 2015;11(2):498-503. doi: 10.4161/21645515.2014.980194.


A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization.

Sanford C, Langley JM, Halperin SA, Zelman M, Mvrvp.

Hum Vaccin Immunother. 2015;11(4):870-4. doi: 10.1080/21645515.2015.1012028.


Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial.

Langley JM, Frenette L, Jeanfreau R, Halperin SA, Kyle M, Chu L, McNeil S, Dramé M, Moris P, Fries L, Vaughn DW.

Vaccine. 2015 Jan 15;33(4):559-67. doi: 10.1016/j.vaccine.2014.11.018. Epub 2014 Nov 21.


Implementation of a universal rotavirus vaccination program: comparison of two delivery systems.

Zelman M, Sanford C, Neatby A, Halperin BA, MacDougall D, Rowswell C, Langley JM, Halperin SA; Maritime Universal Rotavirus Vaccination Program (MURVP).

BMC Public Health. 2014 Sep 2;14:908. doi: 10.1186/1471-2458-14-908.


Incorporating economic evaluation into immunization decision making in Canada: a workshop.

Langley JM, Krahn M, Husereau D, Spika J, Fisman DN, Chit A, Van Exan R.

Expert Rev Vaccines. 2014 Nov;13(11):1291-6. doi: 10.1586/14760584.2014.939637. Epub 2014 Jul 23. No abstract available.


Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls.

Barton M, O'Brien K, Robinson JL, Davies DH, Simpson K, Asztalos E, Langley JM, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Richardson SE.

BMC Infect Dis. 2014 Jun 12;14:327. doi: 10.1186/1471-2334-14-327.


Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age.

Halperin SA, Baine Y, Domachowske JB, Aggarwal N, Simon M, Langley JM, McNeil SA, Friedland LR, Bianco V, Baccarini CI, Miller JM.

J Pediatric Infect Dis Soc. 2014 Mar;3(1):33-42. Epub 2013 Oct 17.


Respiratory syncytial virus-associated intensive care unit admission in children in Southern China.

Zhang Q, Guo Z, Langley JM, Bai Z.

BMC Res Notes. 2013 Nov 8;6:447. doi: 10.1186/1756-0500-6-447.


Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study.

Rozmus J, Junker A, Thibodeau ML, Grenier D, Turvey SE, Yacoub W, Embree J, Haddad E, Langley JM, Ramsingh RM, Singh VA, Long R, Schultz KR.

J Clin Immunol. 2013 Nov;33(8):1310-6.


Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.

Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Cabañas F, Treviño-Garza C, Rodríguez-Weber MA, de la O M, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.

J Infect Dis. 2013 Aug 15;208(4):544-53. doi: 10.1093/infdis/jit263. Epub 2013 Jul 11. Erratum in: J Infect Dis. 2014 May 1;209(9):1494.


Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.

Al-Dabbagh M, Lapphra K, Scheifele DW, Halperin SA, Langley JM, Cho P, Kollmann TR, Li Y, De Serres G, Fortuno ES 3rd, Bettinger JA.

Clin Vaccine Immunol. 2013 Aug;20(8):1108-14. doi: 10.1128/CVI.00659-12. Epub 2013 May 22.


Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E.

JAMA. 2013 May 1;309(17):1793-802. doi: 10.1001/jama.2013.1625.


Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine.

Halperin SA, Ward BJ, Dionne M, Langley JM, McNeil SA, Smith B, Mackinnon-Cameron D, Heyward WL, Martin JT.

Hum Vaccin Immunother. 2013 Jul;9(7):1438-44. doi: 10.4161/hv.24256. Epub 2013 Apr 9.


Splenectomy: reducing the risk of infection.

Langley JM, McNeil S.

CMAJ. 2012 Nov 20;184(17):1926-7. doi: 10.1503/cmaj.112-2085. No abstract available.


A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.

Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V, McNeil SA.

Vaccine. 2012 Sep 28;30(44):6287-93. doi: 10.1016/j.vaccine.2012.08.006. Epub 2012 Aug 16.


Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity.

Langley JM, Reich D, Aggarwal N, Connor D, Lebel MH, Gupta A, Garfield H, Li P, Madan A, Vaughn DW.

Pediatr Infect Dis J. 2012 Aug;31(8):848-58. doi: 10.1097/INF.0b013e31825e6cd6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk